Výsledky vyhledávání - "N M A, Blijlevens"

Akademický článek

The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach

Autor: S. J. M. van Leeuwen, G. B. Proctor, A. Staes, A. M. G. A. Laheij, C. M. J. Potting, M. T. Brennan, I. von Bültzingslöwen, F. R. Rozema, M. D. Hazenberg, N. M. A. Blijlevens, J. E. Raber-Durlacher, M. C. D. N. J. M. Huysmans

Publikováno v: BMC Oral Health, Vol 23, Iss 1, Pp 1-17 (2023)

Abstract Background Oral mucositis is a frequently seen complication in the first weeks after hematopoietic stem cell transplantation recipients which can severely affects patients quality of life. In this study, a labelled and label-free proteomics

Externí odkaz: https://doaj.org/article/19049c3e9a1048aaa67579a61d6089d8

Zobrazit plný text záznamu

Akademický článek

Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra

Autor: H. R. Wardill, C. E. M. de Mooij, A. R. Da Silva Ferreira, H. Havinga, H. J. M. Harmsen, W. J. F. M. van der Velden, L. F. J. van Groningen, W. J. E. Tissing, N. M. A. Blijlevens

Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)

Abstract High-dose chemotherapy causes intestinal inflammation and subsequent breakdown of the mucosal barrier, permitting translocation of enteric pathogens, clinically manifesting as fever. Antibiotics are mainstay for controlling these complicatio

Externí odkaz: https://doaj.org/article/5ddb7407c921495ab646fed28b4b3926

Zobrazit plný text záznamu

Plný text ve formátu HTML

Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy

Autor: C. E. M. de Mooij, W. J. F. M. van der Velden, A. F. J. de Haan, S. Fazel, L. F. J. van Groningen, N. M. A. Blijlevens

Publikováno v: Bone Marrow Transplantation, 57, 9, pp. 1373-1381
Bone Marrow Transplantation, 57, 1373-1381

Item does not contain fulltext Earlier studies have suggested that severe intestinal mucositis (IM; citrulline

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d102ca1ee9995f02833ee06d17d05ec
https://repository.ubn.ru.nl/handle/2066/282628

Zobrazit plný text záznamu

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

Autor: K P van Rhee, S L de Vroom, R M van Hest, P D van der Linden, S H Tonino, E Molendijk, R A A Mathôt, N M A Blijlevens, C A J Knibbe, R J M Bruggemann, S E Geerlings

Publikováno v: Journal of Antimicrobial Chemotherapy, 77, 11, pp. 3069-3076
The Journal of antimicrobial chemotherapy, 77(11), 3069-3076. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77, 3069-3076
Journal of Antimicrobial Chemotherapy, 77(11), 3069-3076. OXFORD UNIV PRESS

Background Patients with haematological malignancies frequently endure neutropenia and gastrointestinal (GI)-mucositis after high-dose chemotherapy. In these patients, ciprofloxacin is used for Gram-negative infection prophylaxis. Objectives We inves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37334b498f4033149b8f929dcbaa33cb
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/287859

Zobrazit plný text záznamu

Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy

Autor: C E M, de Mooij, W J F M, van der Velden, A F J, de Haan, S, Fazel, L F J, van Groningen, N M A, Blijlevens

Publikováno v: Bone marrow transplantation. 57(9)

Earlier studies have suggested that severe intestinal mucositis (IM; citrulline 10 µmol/L) is an independent risk factor for bloodstream infections (BSI) after cytotoxic therapy. Our aim was to grade IM in patients receiving commonly used chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a36707aeed3730cbfecf0ac021b3e641
https://pubmed.ncbi.nlm.nih.gov/35661156

Zobrazit plný text záznamu

Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever

Autor: C.E.M. de Mooij, I. P. van de Peppel, A. R. da Silva Ferreira, Hermie J. M. Harmsen, Wim J. E. Tissing, Hannah R. Wardill, Rick Havinga, N. M. A. Blijlevens

Publikováno v: Cancer Chemotherapy and Pharmacology, 88, 2, pp. 173-188
Cancer Chemotherapy and Pharmacology, 88(2), 173-188. SPRINGER
Cancer Chemotherapy and Pharmacology, 88, 173-188
Cancer Chemotherapy and Pharmacology

Purpose Conditioning therapy with high-dose melphalan (HDM) is associated with a high risk of gut toxicity, fever and infections in haematopoietic stem cell transplant (HSCT) recipients. However, validated preclinical models that adequately reflect c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4b5746cbf6a98f45a1864d820ea0c7
https://repository.ubn.ru.nl/handle/2066/245125

Zobrazit plný text záznamu

Coronary artery spasms due to tyrosine kinase inhibitors used in chronic myeloid leukemia

Autor: R B, Fiets, A H J, Staal, G E, Cramer, N M A, Blijlevens

Publikováno v: The Netherlands journal of medicine. 76(7)

Tyrosine kinase inhibitors (TKIs) have changed the landscape of treatment for patients with chronic myeloid leukemia (CML) leading to a life expectancy comparable to the general population. Side effects commonly encountered during TKI treatment are p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fc803bbd3ff0cb14c632325d3f41ef79
https://pubmed.ncbi.nlm.nih.gov/30220658

Zobrazit plný text záznamu

[Current dilemmas on the transmission of hepatitis E virus]

Autor: E, de Weerd-de Jong, A M, Peters, J C, Rahamat-Langendoen, N M A, Blijlevens

Publikováno v: Nederlands tijdschrift voor geneeskunde. 161

Immunocompromised patients are especially at risk for developing chronic hepatitis E virus (HEV) infection, which may result in progressive liver disease and cirrhosis. In addition, treatment of chronic HEV infection in these patients often includes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d69d885e0e80a193c2d0eed09d2ed406
https://pubmed.ncbi.nlm.nih.gov/29192575

Zobrazit plný text záznamu

The management of critically ill patients with haematological malignancies

Autor: N, Kusadasi, M C A, Müller, D J, van Westerloo, A E C, Broers, M G E C, Hilkens, N M A, Blijlevens On Behalf Of The Hema-Icu Study Group

Publikováno v: The Netherlands journal of medicine. 75(7)

The management of critically ill patients with haematological malignancy (HM) still shows inter- and intra-regional differences. Our objective in this updated review was to address the evidence supporting the potential treatment options, based on mul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b4d2dd1d16237af5bdb3472878040f58
https://pubmed.ncbi.nlm.nih.gov/29667597

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání